263 related articles for article (PubMed ID: 34375393)
1. Cognitive response to testosterone replacement added to intensive lifestyle intervention in older men with obesity and hypogonadism: prespecified secondary analyses of a randomized clinical trial.
Gregori G; Celli A; Barnouin Y; Paudyal A; Armamento-Villareal R; Napoli N; Qualls C; Villareal DT
Am J Clin Nutr; 2021 Nov; 114(5):1590-1599. PubMed ID: 34375393
[TBL] [Abstract][Full Text] [Related]
2. Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism.
Barnouin Y; Armamento-Villareal R; Celli A; Jiang B; Paudyal A; Nambi V; Bryant MS; Marcelli M; Garcia JM; Qualls C; Villareal DT
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1096-e1110. PubMed ID: 33351921
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
[TBL] [Abstract][Full Text] [Related]
4. Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy.
Bhasin S; Seidman S; Travison TG; Pencina KM; Lincoff AM; Nissen SE; Miller MG; Flevaris P; Li X; Wannemuehler KA; Pope HG
J Clin Endocrinol Metab; 2024 Jun; 109(7):1814-1826. PubMed ID: 38205962
[TBL] [Abstract][Full Text] [Related]
5. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial.
Huang G; Wharton W; Bhasin S; Harman SM; Pencina KM; Tsitouras P; Li Z; Hally KA; Asthana S; Storer TW; Basaria S
Lancet Diabetes Endocrinol; 2016 Aug; 4(8):657-665. PubMed ID: 27377542
[TBL] [Abstract][Full Text] [Related]
7. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
Colleluori G; Chen R; Turin CG; Vigevano F; Qualls C; Johnson B; Mediwala S; Villareal DT; Armamento-Villareal R
Front Endocrinol (Lausanne); 2020; 11():277. PubMed ID: 32499757
[No Abstract] [Full Text] [Related]
8. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men.
Lašaitė L; Čeponis J; Preikša RT; Žilaitienė B
Andrologia; 2017 Apr; 49(3):. PubMed ID: 27545990
[TBL] [Abstract][Full Text] [Related]
9. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
Bhasin S; Travison TG; Pencina KM; O'Leary M; Cunningham GR; Lincoff AM; Nissen SE; Lucia MS; Preston MA; Khera M; Khan N; Snabes MC; Li X; Tangen CM; Buhr KA; Thompson IM
JAMA Netw Open; 2023 Dec; 6(12):e2348692. PubMed ID: 38150256
[TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.
Sih R; Morley JE; Kaiser FE; Perry HM; Patrick P; Ross C
J Clin Endocrinol Metab; 1997 Jun; 82(6):1661-7. PubMed ID: 9177359
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
12. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.
Bhasin S; Lincoff AM; Nissen SE; Wannemuehler K; McDonnell ME; Peters AL; Khan N; Snabes MC; Li X; Li G; Buhr K; Pencina KM; Travison TG
JAMA Intern Med; 2024 Apr; 184(4):353-362. PubMed ID: 38315466
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.
Seidman SN; Spatz E; Rizzo C; Roose SP
J Clin Psychiatry; 2001 Jun; 62(6):406-12. PubMed ID: 11465516
[TBL] [Abstract][Full Text] [Related]
14. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.
Resnick SM; Matsumoto AM; Stephens-Shields AJ; Ellenberg SS; Gill TM; Shumaker SA; Pleasants DD; Barrett-Connor E; Bhasin S; Cauley JA; Cella D; Crandall JP; Cunningham GR; Ensrud KE; Farrar JT; Lewis CE; Molitch ME; Pahor M; Swerdloff RS; Cifelli D; Anton S; Basaria S; Diem SJ; Wang C; Hou X; Snyder PJ
JAMA; 2017 Feb; 317(7):717-727. PubMed ID: 28241356
[TBL] [Abstract][Full Text] [Related]
15. Role of testosterone in cognition and mobility of aging men.
Kaufman JM; Lapauw B
Andrology; 2020 Nov; 8(6):1567-1579. PubMed ID: 32700462
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy in obese males.
Drewa T; Olszewska-Słonina D; Chlosta P
Acta Pol Pharm; 2011; 68(5):623-7. PubMed ID: 21928705
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression).
Shores MM; Kivlahan DR; Sadak TI; Li EJ; Matsumoto AM
J Clin Psychiatry; 2009 Jul; 70(7):1009-16. PubMed ID: 19653976
[TBL] [Abstract][Full Text] [Related]
18. Effect of Lifestyle Intervention on the Hormonal Profile of Frail, Obese Older Men.
Armamento-Villareal R; Aguirre LE; Qualls C; Villareal DT
J Nutr Health Aging; 2016 Mar; 20(3):334-40. PubMed ID: 26892583
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.
Pencina KM; Travison TG; Artz AS; Lincoff AM; Nissen SE; Flevaris P; Chan A; Li X; Diegel SA; Wannemuehler K; Bhasin S
JAMA Netw Open; 2023 Oct; 6(10):e2340030. PubMed ID: 37889486
[TBL] [Abstract][Full Text] [Related]
20. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
